An 8-year-old girl with partial ornithine carbamoyl transferase deficiency was treated with sodium benzoate (200 mg/kg/day) for 13 months. Before administration of sodium benzoate, her protein intake was reduced to 1.0 to 1.5 g/kg/day and her caloric intake fluctuated. Hy perammonemic attacks were frequently observed in winter. After the start of administration of sodium benzoate, the severity and frequency of these attacks decreased, although her protein intake was increased to 1.5 to 2.0 g/kg/day. No adverse effect of sodium benzoate were detected by clinical and laboratory examinations. It is concluded that long-term oral administration of sodium benzoate was effective in reducing the frequency and severity of hyperammonemic attacks in this patient. Sodium benzoate therapy in combination with dietary manipulation may improve the growth and development of these patients by allowing reduced dietary protein restriction.
Get full access to this article
View all access options for this article.
References
1.
Campbell Agm , Rosenberg JR, Snodgrass PJ, et al. Ornithine transcarbamylase deficiency, a case of lethal neonatal hyperammonemia in males. N Engl J Med1973;288:1.
2.
McReynolds JW , Mantagos S., Brusilow S., et al. Treatment of complete ornithine transcarbamylase deficiency with nitrogen-free analogues of essential amino acids. J Pediatr1973;93:421.
3.
Batshaw ML, Thomas GH, Brusilow SHNew approaches to the diagnosis and treatment of inborn errors of urea synthesis . Pediatrics1981:68:290.
4.
Brusilow SW, Tinker J., Batshaw MLAmino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis. Science1980:207:659.
5.
Brusilow SW, Valle DL, Batshaw MLNew pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet1979;2:452.
6.
Shih VEUrea cycle disorders. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1978:362-86.
7.
Sunshine P., Lindenbaum JE, Levy HL, et al. Hyperammonemia due to a defect in hepatic ornithine transcarbamylase . Pediatrics1972;50:100.
8.
Batshaw ML, Brusilow S., Waber L., et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med1982:306:1387.
9.
Baumgartner R., Ando T., Nyhan WLNonketotic hyperglycinemia. J Pediatr1969;75:1022.
10.
Trijbels Jmf , Monnes LA, van der Zee SP, et al. A patient with non-ketotic hyperglycinemia: biochemical findings and therapeutic approaches. Pediatr Res1974;8:598.
11.
Woolf LIToxicity of phenylacetic acid used in treating hyperammonia. J Inher Metab Dis1980;3:61.
12.
O'Connor JE , Ribelles M., Grisolia S.Potentiation of hyperammonemia by sodium benzoate in animals. A note of caution. Eur J Pediatr1982;138:186.
13.
Batshaw ML, Brusilow SWEvidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies. J Inher Metab Dis1981:4:231.
14.
Batshaw ML, Painter MJ, Sproul GT, et al. Therapy of urea cycle enzymopathies: Three case studies. Johns Hopkins Med J1981;148:34.
